Article info
PostScript
Letter
Hepatitis B reactivation: reducing the risk in patients with inflammatory bowel disease
- Correspondence to Prof Patrick T F Kennedy, Barts Liver Centre, Barts and The London School of Medicine and Dentistry, London E1 2AT, UK; p.kennedy{at}qmul.ac.uk
Citation
Hepatitis B reactivation: reducing the risk in patients with inflammatory bowel disease
Publication history
- Received July 15, 2019
- Revised January 20, 2020
- Accepted January 22, 2020
- First published January 30, 2020.
Online issue publication
October 07, 2020
Article Versions
- Previous version (30 January 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.